Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04415177 · ClinicalTrials.gov registry record · NA
Virtual Reality Trial Using EaseVRx For Chronic Low Back Pain
A NA study, sponsored by AppliedVR.
- Completed
- Registry status
- NA
- Development phase
- 188
- Enrollment target
NCT04415177: Completed NA study, sponsored by AppliedVR.
NCT04415177 is a NA study that has completed, run by AppliedVR. The registered enrollment target is 188 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (87% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04415177, a NA study, has completed, sponsored by AppliedVR.
- COMPLETED
- Registry status
- NA
- Development phase
- 188 participants
- Enrollment target
Study Summary
Randomized, 2-arm parallel group clinical trial evaluating the effectiveness of a self-administered Virtual Reality program for the treatment of chronic lower back pain compared to a placebo VR program.
Primary Outcome
DoD/VA Pain scale measures pain intensity, and inference around activity, sleep, mood, and stress, each on an 11-point scale. The max score is 50 and the minimum is 0. The higher the score the worse the outcome. This will be assessed twice weekly during the 8-week intervention intervention period.
Interventions
- DEVICE EaseVRx headset with active intervention
- DEVICE EaseVRx headset without active intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 188 participants |
| Start Date | 2020-07-01 |
| Est. Completion | 2021-04-30 |
| Phase | NA |
What the finished NCT04415177 record still lists
NCT04415177 is an interventional study that assigns participants to a tested intervention. The registered 188 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (87% lower).
The record links to 0 conditions, and to 2 interventions - of which EaseVRx headset with active intervention is the first listed.
NCT04415177 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04415177 about?
NCT04415177 is a clinical study titled "Virtual Reality Trial Using EaseVRx For Chronic Low Back Pain". Randomized, 2-arm parallel group clinical trial evaluating the effectiveness of a self-administered Virtual Reality program for the treatment of chronic lower back pain compared to a placebo VR program.
What is the current status of trial NCT04415177?
This trial is currently completed. It is a NA study. The enrollment target is 188 participants. The study started on 2020-07-01. Estimated completion is 2021-04-30.
What interventions are being tested in trial NCT04415177?
The interventions under investigation include: EaseVRx headset with active intervention (DEVICE), EaseVRx headset without active intervention (DEVICE).
Who is sponsoring clinical trial NCT04415177?
This trial is sponsored by AppliedVR, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04415177's enrollment target sits among peer trials
188 576th of 2000 higher than 1,422 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03422198 · 188 participants · Phase 3
Short Course Vaginal Cuff Brachytherapy in Treating Participants With Stage I-II Endometrial Cancer
- NCT04469790 · 188 participants · NA
Effects of Multi-day Interruptions in Sitting on Type 2 Diabetes-relevant Outcomes in Children
- NCT04671667 · 188 participants · Phase 2
Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma
- NCT04853251 · 188 participants · Phase 4
A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration (nAMD) Treated With the Port Delivery System With Ranibizumab (PDS)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI